U.S. health secretary Robert F. Kennedy Jr. said on Wednesday at a Senate Committee on Health, Education, Labor & Pensions hearing that he is willing to work with Democrats on lowering prescription drug prices.

The cost of prescription drugs have risen rapidly despite policymakers pledging to fix the issue. They climbed nearly 40% since 2014, according to data from GoodRx.

As in negotiations with foreign nations, minor concessions by drug companies are more likely than a true overhaul.

President Trump will hold a press conference Monday morning with Health and Human Services Secretary Robert F. Kennedy Jr. to announce an executive order to cap prescription drug and pharmaceutical prices at the lowest cost offered in any other country.

Health and Human Services Secretary Robert F. Kennedy Jr. said that bringing the cost of prescription drugs to levels seen in Europe largely depends on how drug companies cooperate.